J. Netelenbos

发表

Predicting fractures in an international cohort using risk factor algorithms without BMD

A. LaCroix, D. Hosmer, C. Cooper, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop

R. Ravazzolo, E. Hsiao, G. Pals, 2021, Frontiers in Endocrinology.

Collaboration Around Rare Bone Diseases Leads to the Unique Organizational Incentive of the Amsterdam Bone Center

W. Lems, G. Pals, A. Lammertsma, 2020, Frontiers in Endocrinology.

A 2-year, randomized, comparative, placebo-controlled study on the effects of raloxifene on lipoprotein(a) and homocysteine.

W. M. van Baal, P. Kenemans, T. Vogelvang, 2002, Maturitas.

Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection.

C. Stehouwer, P. Kenemans, J. C. Netelenbos, 1999, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Spine radiographs to improve the identification of women at high risk for fractures

P. Geusens, W. Lems, J. C. Netelenbos, 2009, Osteoporosis International.

Growth hormone induces tyrosine phosphorylation of annexin I in rat osteosarcoma cells.

J. Salles, J. C. Netelenbos, M. Slootweg, 1996, Endocrinology.

Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells.

C. Ohlsson, J. Salles, J. C. Netelenbos, 1995, Endocrinology.

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2014): Oral Communication Abstracts

A. LaCroix, D. Hosmer, C. Cooper, 2014, Osteoporosis International.

Determinants of vitamin D status in patients with hip fracture and in elderly control subjects.

P. Lips, F. V. Van Ginkel, J. C. Netelenbos, 1987, The American journal of clinical nutrition.

Oral 17&bgr;-estradiol (1 mg) continuously combined with dydrogesterone improves the serum lipid profile of postmenopausal women

O. Chevallier, J. C. Netelenbos, B. Pornel, 2002, Menopause.

Empirically based composite fracture prediction model from the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW).

A. LaCroix, D. Hosmer, C. Cooper, 2014, The Journal of clinical endocrinology and metabolism.

Risk Factors for Treatment Failure With Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW)

A. LaCroix, C. Cooper, S. Silverman, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Previous fractures at multiple sites increase the risk for subsequent fractures: The global longitudinal study of osteoporosis in women

A. LaCroix, C. Cooper, S. Boonen, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design

A. LaCroix, C. Cooper, S. Silverman, 2009, Osteoporosis International.

Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women

A. LaCroix, C. Cooper, S. Silverman, 2012, Osteoporosis International.

Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis

H. E. van der Horst, J. C. Netelenbos, P. Elders, 2019, Osteoporosis International.

Obesity is not protective against fracture in postmenopausal women: GLOW.

Julie Flahive, Kenneth G Saag, Steven Boonen, 2011, The American journal of medicine.

The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects.

P. Delmas, F. V. Van Ginkel, J. C. Netelenbos, 1988, The Journal of clinical endocrinology and metabolism.

Biochemical parameters of bone turnover during ten days of bed rest and subsequent mobilization.

J. Nauta, P. Lips, G. Hazenberg, 1991, Bone and mineral.

Simultaneous determination of 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, and 1,25-dihydroxyvitamin D in plasma or serum.

J. C. Netelenbos, M. Jongen, P. Lips, 1981, Clinical chemistry.

Bone metabolism markers and bone mass in healthy pubertal boys and girls

H. Delemarre-van de Waal, J. C. Netelenbos, J. Roos, 2002, Clinical endocrinology.

Camurati–Engelmann disease (progressive diaphyseal dysplasia) in a Moroccan family

K. Janssens, W. Hul, J. Veenstra, 2005, Osteoporosis International.

Dexamethasone increases and serum decreases growth hormone receptor binding to UMR-106.01 rat osteosarcoma cells.

J. Salles, J. C. Netelenbos, C. P. de Vries, 1994, Endocrinology.

Raloxifene and hormone replacement therapy increase arachidonic acid and docosahexaenoic acid levels in postmenopausal women.

E. Giltay, E. J. Duschek, M. Katan, 2004, The Journal of endocrinology.

Histomorphometric profile and vitamin D status in patients with femoral neck fracture.

F. V. Van Ginkel, J. C. Netelenbos, M. Jongen, 1982, Metabolic bone disease & related research.

Bone histomorphometry and serum concentrations of intact parathyroid hormone (PTH(1-84)) in patients with primary hyperparathyroidism.

J. C. Netelenbos, P. Lips, W. Hackeng, 1993, Bone and mineral.

Growth hormone receptor activity is stimulated by insulin-like growth factor binding protein 5 in rat osteosarcoma cells.

C. Ohlsson, J. C. Netelenbos, D. Andress, 1996, Growth regulation.

Estrogen Regulation of Intestinal Calcium Absorption in the Intact and Ovariectomized Adult Rat

J. C. Netelenbos, W. van der Vijgh, R. Barto, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

An analysis of bone structure in patients with hip fracture.

J C Netelenbos, J. C. Netelenbos, P. Lips, 1987, Bone and mineral.

Pubertal Maturation Characteristics and the Rate of Bone Mass Development Longitudinally Toward Menarche

H. Delemarre-van de Waal, M. V. van’t Hof, J. C. Netelenbos, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Intranasal calcitonin suppresses increased bone resorption during short‐term immobilization: A double‐blind study of the effects of intranasal calcitonin on biochemical parameters of bone turnover

G. Kwakkel, J. Nauta, P. Lips, 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone marrow and bone remodeling.

F. V. Van Ginkel, J. C. Netelenbos, P. Lips, 1985, Bone.

The relation between periodontitis and systemic bone mass in women between 46 and 55 years of age.

J. C. Netelenbos, P. van der Stelt, L. Habets, 1992, Journal of clinical periodontology.

Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW)

A. LaCroix, C. Cooper, S. Silverman, 2010, Osteoporosis International.

Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study

A. LaCroix, C. Cooper, S. Silverman, 2013, Osteoporosis International.

Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW)

A. LaCroix, C. Cooper, S. Silverman, 2012, Osteoporosis International.

Growth hormone (replacement) therapy in adults: bone and calcium metabolism.

J. C. Netelenbos, E. van der Veen, J. Netelenbos, 1990, Hormone research.

Human pharmacokinetics of orally administered strontium

O. Leeuwenkamp, P. Lips, W. J. Vijgh, 1990, Calcified Tissue International.

[Estrogen agonists, especially raloxifene, in the treatment of osteoporosis].

P. Lips, J. Netelenbos, 1996, Nederlandsch tijdschrift voor geneeskunde.

Intestinal strontium absorption: from bioavailability to validation of a simple test representative for intestinal calcium absorption.

J. C. Netelenbos, W. van der Vijgh, R. Barto, 1995, Clinical chemistry.

Seasonal variation in serum concentrations of parathyroid hormone in elderly people.

F. V. Van Ginkel, J. C. Netelenbos, M. Jongen, 1983, The Journal of clinical endocrinology and metabolism.

Histomorphometric analysis reveals reduced bone mass and bone formation in patients with quiescent Crohn's disease.

P. Lips, D. Hommes, C. J. van der Woude, 2011, Gastroenterology.

Perimenopausal bone mass and risk factors.

P. Lips, F. V. Van Ginkel, J. C. Netelenbos, 1989, Bone and mineral.

Estrogen enhances growth hormone receptor expression and growth hormone action in rat osteosarcoma cells and human osteoblast-like cells.

C. Ohlsson, J. C. Netelenbos, O. Isaksson, 1997, The Journal of endocrinology.

An international comparison of vitamin D metabolite measurements.

F. V. Van Ginkel, J. C. Netelenbos, M. Jongen, 1984, Clinical chemistry.

Analysis for 1,25-dihydroxyvitamin D in human plasma, after a liquid-chromatographic purification procedure, with a modified competitive protein-binding assay.

J. C. Netelenbos, M. Jongen, W. van der Vijgh, 1981, Clinical chemistry.

Interlaboratory Variation of Vitamin D Metabolite Measurements

R. Bosch, T. Visser, J. C. Netelenbos, 1982, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

Pharmacokinetics of 24,25-Dihydroxyvitamin D3 in Humans

J. C. Netelenbos, M. Jongen, P. Lips, 1989, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Human Pharmacokinetics of Orally Administered (24 R)-Hydroxycalcidiol

O. Leeuwenkamp, J. C. Netelenbos, P. Lips, 1993, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Vitamin D status in urinary calcium stone formation.

F. V. Van Ginkel, J. C. Netelenbos, M. Jongen, 1985, Archives of internal medicine.

Effect of estrogen on intestinal strontium absorption in postmenopausal women.

J. C. Netelenbos, W. van der Vijgh, R. Barto, 2000, Maturitas.

Long‐term effect of calcium supplementation on bone loss in perimenopausal women

F. V. Van Ginkel, J. C. Netelenbos, P. van der Stelt, 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

SimultaneousDeterminationof 25-HydroxyvitaminD , 24 , 25-DihydroxyvitaminD , and 1 , 25-DihydroxyvitaminD in Plasmaor Serum

P. Lips, M. Jongen, W. J. Vijgh, 2004 .

Topically applied low-dose calcitriol has no calciotropic effect in patients with stable plaque psoriasis.

J. C. Netelenbos, C. Nieboer, W. van der Vijgh, 1994, Journal of the American Academy of Dermatology.

Effect of a single infusion of aminohydroxypropylidene on calcium and bone metabolism in healthy volunteers monitored during 2 months.

F. V. Van Ginkel, O. Leeuwenkamp, J. C. Netelenbos, 1991, The Journal of clinical endocrinology and metabolism.

Measurement of vitamin D metabolites in anephric subjects.

J. C. Netelenbos, M. Jongen, P. Lips, 1984, Nephron.

Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age.

P. Lips, F. V. Van Ginkel, O. Leeuwenkamp, 1991, The Journal of clinical endocrinology and metabolism.

Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women.

A. LaCroix, C. Cooper, S. Boonen, 2010, Mayo Clinic proceedings.

[Teriparatide: an anabolic drug for the treatment of patients with osteoporosis].

W. Lems, J. C. Netelenbos, N. Hamdy, 2006, Nederlands tijdschrift voor geneeskunde.

Stimulation and suppression of intact parathyroid hormone (PTH1–84) in normal subjects and hyperparathyroid patients

J. C. Netelenbos, P. Lips, W. Hackeng, 1991, Clinical endocrinology.

Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patients.

J. C. Netelenbos, P. Lips, C. Lips, 1986, The Journal of clinical endocrinology and metabolism.

Daily Oral Pamidronate in Women and Men With Osteoporosis: A 3‐Year Randomized Placebo‐Controlled Clinical Trial With a 2‐Year Open Extension

A. Zwinderman, P. Lips, E. McCloskey, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Adherence and profile of non-persistence in patients treated for osteoporosis—a large-scale, long-term retrospective study in The Netherlands

P. Geusens, J. C. Netelenbos, P. Geusens, 2010, Osteoporosis International.

A commentary on steroid treatment in multiple sclerosis.

C. Polman, G. Teule, J. C. Netelenbos, 1991, Archives of neurology.

Corticosteroids and bone mass.

C. Polman, H. E. van der Wiel, J. Netelenbos, 1990, Annals of internal medicine.

An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis: a prospective multinational cohort study (GLOW)

C. Cooper, S. Boonen, A. Díez-Pérez, 2012, Annals of the rheumatic diseases.

Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW).

A. LaCroix, C. Cooper, S. Boonen, 2012, Bone.

Accelerated vertebral bone loss in relation to the menopause: a cross-sectional study on lumbar bone density in 286 women of 46 to 55 years of age.

F. V. Van Ginkel, J. C. Netelenbos, P. van der Stelt, 1988, Bone and mineral.

Bone Histomorphometric Evaluation of Pamidronate Treatment in Clinically Manifest Osteoporosis

P. Lips, J. C. Netelenbos, S. Papapoulos, 1999, Osteoporosis International.

Selective determination of hydroxyproline in urine by high-performance liquid chromatography using precolumn derivatization.

J. C. Netelenbos, T. Teerlink, P. Tavenier, 1989, Clinica chimica acta; international journal of clinical chemistry.

Estrogen replacement therapy continuously combined with four different dosages of dydrogesterone: effect on calcium and lipid metabolism.

P. Kenemans, J. C. Netelenbos, G. Voetberg, 1994, The Journal of clinical endocrinology and metabolism.

The effect of cross‐gender hormonal treatment on bone metabolism in male‐to‐female transsexuals

P. Lips, L. Gooren, J. C. Netelenbos, 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Lower mobility and markers of bone resorption in the elderly.

F. V. Van Ginkel, J. C. Netelenbos, P. Lips, 1990, Bone and mineral.

Hypercalcemia and J waves.

F. Verheugt, J. Netelenbos, S. H. de Rijk, 1987, The American journal of cardiology.

Oestrogen has no short‐term effect on intestinal strontium absorption in healthy postmenopausal women

J. C. Netelenbos, W. van der Vijgh, R. Barto, 1999, Clinical endocrinology.

Effects of short-term low-dose heparin administration on biochemical parameters of bone turnover.

P. Lips, J. C. Netelenbos, P. Huijgens, 1993, Bone and mineral.

Generation of Fibrodysplasia ossificans progressiva and control integration free iPSC lines from periodontal ligament fibroblasts.

M. Goumans, J. C. Netelenbos, D. de Jong, 2019, Stem cell research.

Clinical Utility Gene Card for: Fibrodysplasia ossificans progressiva

G. Pals, A. Bullock, F. Ventura, 2015, European Journal of Human Genetics.

Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal women.

J. C. Netelenbos, J. Roos, R. Evertz, 2002, Bone.

Microarchitecture of Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva: An HR-pQCT Case Series

B. van Rietbergen, J. C. Netelenbos, J. V. D. van den Bergh, 2021, Frontiers in Cell and Developmental Biology.

Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women.

C. Stehouwer, J. C. Netelenbos, T. Teerlink, 2003, Clinical science.

Raloxifene affects brain activation patterns in postmenopausal women during visual encoding.

S. Rombouts, P. Scheltens, F. Barkhof, 2001, The Journal of clinical endocrinology and metabolism.

Quantification of strontium in plasma and urine with flameless atomic absorption spectrometry.

O. Leeuwenkamp, J. C. Netelenbos, P. Lips, 1989, Clinical chemistry.

Oral 17β-Estradiol Continuously Combined with Dydrogesterone Lowers Serum Lipoprotein(a) Concentrations in Healthy Postmenopausal Women1

P. Kenemans, J. C. Netelenbos, G. Kamp, 1997 .

Bone mineral content of transilial biopsies in patients with hip fracture.

E. Hogervorst, J. C. Netelenbos, P. Lips, 1985, Bone.

Increase in Fracture Risk Following Unintentional Weight Loss in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women

A. LaCroix, C. Cooper, A. Díez-Pérez, 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2014): Oral Communication Abstracts

E. Siris, F. Hooven, S. Gehlbach, 2014, Osteoporosis International.

Strontium as a marker for intestinal calcium absorption: the stimulatory effect of calcitriol.

J. C. Netelenbos, W. van der Vijgh, R. Barto, 2000, Clinical chemistry.

Radiologic morphometry in patients with femoral neck fractures and elderly control subjects. Comparison with histomorphometric parameters.

F. V. Van Ginkel, J. C. Netelenbos, P. Lips, 1984, Clinical orthopaedics and related research.

Reply to “Screening for high fracture risk”

P. Elders, K. Swart, T. Merlijn, 2020, Osteoporosis International.

The Effect of a Screening and Treatment Program for the Prevention of Fractures in Older Women: A Randomized Pragmatic Trial

F. Rutters, A. A. van der Heijden, M. Heymans, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Raloxifene reduces procarboxypeptidase U, an antifibrinolytic marker. A 2-year randomized, placebo-controlled study in healthy early postmenopausal women

P. Kenemans, T. Vogelvang, J. C. Netelenbos, 2004, Menopause.

The effect of trauma on serum concentrations of vitamin D metabolites in patients with hip fracture.

F. V. Van Ginkel, R. Bouillon, J. C. Netelenbos, 1985, Bone.

[Vitamin D deficiency and hip fracture].

J. C. Netelenbos, P. Lips, J. Netelenbos, 1985, Tijdschrift voor gerontologie en geriatrie.

Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women

A. LaCroix, C. Cooper, S. Silverman, 2012, Osteoporosis International.

Impact of Prevalent Fractures on Quality of Life: Baseline Results from the Global Longitudinal Study of Osteoporosis in Women Repository Citation

E. Siris, K. Saag, F. Hooven, 2022 .

Self-perception of fracture risk: what can it tell us?

S. Silverman, E. Siris, K. Saag, 2017, Osteoporosis International.